Etanercept therapy in two patients with psoriasis and concomitant hepatitis C

Journal of the American Academy of Dermatology

Volumn 54, Issue 6, 2006, Pages 1102-1104

  De Simone, Clara ^a   Paradisi, Andrea ^a   Capizzi, Rodolfo ^a   Carbone, Angelo ^a   Siciliano, Massimo ^b   Amerio, Pier Luigi ^a  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^b Istituto di Patologia Speciale Medica e Semeiotica Medica   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ETANERCEPT; RIBAVIRIN;

ADULT; ARTICLE; BIOPSY; CASE REPORT; CLINICAL FEATURE; DISEASE EXACERBATION; DRUG SAFETY; HEPATITIS C; HUMAN; HUMAN TISSUE; LIVER DISEASE; LIVER FUNCTION; MALE; PRIORITY JOURNAL; PSORIASIS; TREATMENT OUTCOME;

ADULT; HEPATITIS C; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PSORIASIS; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT FUSION PROTEINS;

EID: 33646679399     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2005.11.1035     Document Type: Article

References (7)

1. Magliocco M.A., and Gottlieb A.B. Etanercept therapy for patients with psoriatic arthritis and concurrent hepatitis C virus infection: report of 3 cases. J Am Acad Dermatol 51 (2004) 580-584
2. Gottlieb A.B. Etanercept for the treatment of psoriasis and psoriatic arthritis. Dermatol Ther 17 (2004) 401-408
3. Nasir A., Arora H.S., and Kaiser H.E. Apoptosis and pathogenesis of viral hepatitis C: an update. In Vivo 14 (2000) 297-300
4. Nelson D.R., Lim H.L., Marousis C.G., Fang J.W., Davis G.L., Shen L., et al. Activation of tumor necrosis factor-alpha system in chronic hepatitis C virus infection. Dig Dis Sci 42 (1997) 2487-2494
5. Calabrese L.H., Zein N., and Vassilopoulos D. Safety of antitumor necrosis factor (anti-TNF) therapy in patients with chronic viral infections: hepatitis C, hepatitis B, and HIV infection. Ann Rheum Dis 63 Suppl II (2004) ii18-ii24
6. Peterson J.R., Hsu F.C., Simkin P.A., and Wener M.H. Effect of tumor necrosis factor alpha antagonists on serum transaminases and viraemia in patients with rheumatoid arthritis and chronic hepatitis C infection. Ann Rheum Dis 62 (2003) 1078-1082
7. Zein N.N., and the Etanercept Study Group. Etanercept as an adjuvant to interferon and ribavirin in treatment-naïve patients with chronic hepatitis C virus infection: a phase 2 randomized, double-blind, placebo-controlled study. J Hepatol 42 (2005) 315-322